Results 171 to 180 of about 48,441 (262)

Optimal Treatment Selection for Cesarean Scar Pregnancy: Using a Predictive Score of Intraoperative Blood Loss: A Prospective Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims The significant risk associated with treatment for cesarean scar pregnancy (CSP) is the potential for severe hemorrhage at termination, resulting in controversy over optimal treatment and no international standards. Our previous study proposed that estimating intraoperative blood loss from ultrasound findings, called ...
Yunhui Tang   +8 more
wiley   +1 more source

Optimizing outcomes in intrauterine insemination: A narrative synthesis of two decades of clinical research (2000–2024)

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 2, Page 718-729, August 2026.
Abstract Intrauterine insemination (IUI) is a widely used first‐line fertility treatment, yet its success rates vary considerably. This review synthesizes evidence from peer‐reviewed studies published between 2000 and 2024, including randomized controlled trials, cohort and case–control studies, as well as systematic and narrative reviews identified ...
Kasuni Akalanka
wiley   +1 more source

Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: A systematic review and a meta‐analysis

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 2, Page 608-620, August 2026.
Abstract Background Poor ovarian response (POR) complicates a substantial proportion of in vitro fertilization (IVF) cycles, frequently causing cycle cancellation and suboptimal reproductive outcomes. Conventional follicular‐phase ovarian stimulation (FPOS) protocols often yield limited results, prompting the evaluation of alternative strategies such ...
Vittorio Agrifoglio   +8 more
wiley   +1 more source

Timing of conception after methotrexate and subsequent pregnancy outcomes: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 2, Page 1061-1069, August 2026.
Abstract Objective Methotrexate is widely used to treat ectopic pregnancy (EP). Concerns about its teratogenicity have led to uncertainty regarding the optimal interval before attempting conception. Guidelines recommend a 3‐month washout period, while the manufacturer advises 6 months. Evidence on the safety of early conception is limited.
Bar Rosh, Joul Hadad, Naomi Gronich
wiley   +1 more source

Home - About - Disclaimer - Privacy